Advances in gene/cell therapy in epidermolysis Bullosa

Keio Journal of Medicine

Volumn 64, Issue 2, 2015, Pages 21-25

  Murauer, Eva M ^a   Koller, Ulrich ^a   Pellegrini, Graziella ^b   De Luca, Michele ^b   Bauer, Johann W ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Epidermolysis bullosa; Gene cell therapy

Indexed keywords

TRANSCRIPTION ACTIVATOR LIKE EFFECTOR NUCLEASE; ZINC FINGER NUCLEASE;

ALLOGENEIC STEM CELL TRANSPLANTATION; CALCINOSIS; CELL THERAPY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; EPIDERMOLYSIS BULLOSA; GENE MUTATION; GENE THERAPY; GENOTOXICITY; HUMAN; IMMUNE RESPONSE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; WOUND CLOSURE; ANIMAL; KERATINOCYTE; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; EPIDERMOLYSIS BULLOSA; GENETIC THERAPY; HUMANS; KERATINOCYTES; STEM CELL TRANSPLANTATION;

EID: 84933532731     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.2014-0013-RE     Document Type: Review

References (33)

1. Uitto J, Christiano AM: Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. J Clin Invest 1992; 90: 687-692. [Medline] [CrossRef]
2. Fine JD, Hintner H: Life with Epidermolysis Bullosa (EB): Etiology, Diagnosis, Multidisciplinary Care and Therapy, Vienna, Springer, 2009; ISBN 978-3-211-79271-1.
3. Fine JD, Bruckner-Tuderman L, Eady RA, Bauer EA, Bauer JW, Has C, Heagerty A, Hintner H, Hovnanian A, Jonkman MF, Leigh I, Marinkovich MP, Martinez AE, McGrath JA, Mellerio JE, Moss C, Murrell DF, Shimizu H, Uitto J, Woodley D, Zambruno G: Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70: 1103-1126. [Medline] [CrossRef]
4. Woodley DT, Keene DR, Atha T, Huang Y, Lipman K, Li W, Chen M: Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med 2004; 10: 693-695. [Medline] [CrossRef]
5. Remington J, Wang X, Hou Y, Zhou H, Burnett J, Muirhead T, Uitto J, Keene DR, Woodley DT, Chen M: Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 2009; 17: 26-33. [Medline] [CrossRef]
6. Woodley DT, Wang X, Amir M, Hwang B, Remington J, Hou Y, Uitto J, Keene D, Chen M: Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol 2013; 133: 1910-1913. [Medline] [CrossRef]
7. Wong T, Gammon L, Liu L, Mellerio JE, Dopping-Hepenstal PJ, Pacy J, Elia G, Jeffery R, Leigh IM, Navsaria H, McGrath JA: Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2008; 128: 2179-2189. [Medline] [CrossRef]
8. Woodley DT, Remington J, Huang Y, Hou Y, Li W, Keene DR, Chen M: Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 2007; 15: 628-635. [Medline] [CrossRef]
9. Ortiz-Urda S, Lin Q, Green CL, Keene DR, Marinkovich MP, Khavari PA: Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest 2003; 111: 251-255. [Medline] [CrossRef]
10. Wagner JE, Ishida-Yamamoto A, McGrath JA, Hordinsky M, Keene DR, Woodley DT, Chen M, Riddle MJ, Osborn MJ, Lund T, Dolan M, Blazar BR, Tolar J: Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363: 629-639. [Medline] [CrossRef]
11. Murauer EM, Gache Y, Gratz IK, Klausegger A, Muss W, Gruber C, Meneguzzi G, Hintner H, Bauer JW: Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa. J Invest Dermatol 2011; 131: 74-83. [Medline] [CrossRef]
12. Gache Y, Baldeschi C, Del Rio M, Gagnoux-Palacios L, Larcher F, Lacour JP, Meneguzzi G: Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum Gene Ther 2004; 15: 921-933. [Medline] [CrossRef]
13. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, Khavari PA: Stable nonviral genetic correction of inherited human skin disease. Nat Med 2002; 8: 1166-1170. [Medline] [CrossRef]
14. Chen M, Kasahara N, Keene DR, Chan L, Hoeffler WK, Finlay D, Barcova M, Cannon PM, Mazurek C, Woodley DT: Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 2002; 32: 670-675. [Medline] [CrossRef]
15. Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, Maruggi G, Ferrari G, Provasi E, Bonini C, Capurro S, Conti A, Magnoni C, Giannetti A, De Luca M: Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 2006; 12: 1397-1402. [Medline] [CrossRef]
16. Siprashvili Z, Nguyen NT, Bezchinsky MY, Marinkovich MP, Lane AT, Khavari PA: Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue. Hum Gene Ther 2010; 21: 1299-1310. [Medline] [CrossRef]
17. Titeux M, Pendaries V, Zanta-Boussif MA, Décha A, Pironon N, Tonasso L, Mejia JE, Brice A, Danos O, Hovnanian A: SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther 2010; 18: 1509-1518. [Medline] [CrossRef]
18. Melo SP, Lisowski L, Bashkirova E, Zhen HH, Chu K, Keene DR, Marinkovich MP, Kay MA, Oro AE: Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant. Mol Ther 2014; 22: 725-733. [Medline] [CrossRef]
19. Gaj T, Gersbach CA, Barbas CF: ZFN, TALEN, and CRISPR/ Cas-based methods for genome engineering. Trends Biotechnol 2013; 31: 397-405. [Medline] [CrossRef]
20. Spirito F, Meneguzzi G, Danos O, Mezzina M: Cutaneous gene transfer and therapy: the present and the future. J Gene Med 2001; 3: 21-31. [Medline] [CrossRef]
21. Ronfard V, Rives JM, Neveux Y, Carsin H, Barrandon Y: Longterm regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation 2000; 70: 1588-1598. [Medline] [CrossRef]
22. Weber F, Bauer JW, Sepp N, Högler W, Salmhofer W, Hintner H, Fritsch P: Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm Venereol 2001; 81: 189-192. [Medline] [CrossRef]
23. Robbins PB, Lin Q, Goodnough JB, Tian H, Chen X, Khavari PA: In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci USA 2001; 98: 5193-5198. [Medline] [CrossRef]
24. Hengge UR: Gene therapy progress and prospects: the skin - easily accessible, but still far away. Gene Ther 2006; 13: 1555-1563. [Medline] [CrossRef]
25. Larcher F, Dellambra E, Rico L, Bondanza S, Murillas R, Cattoglio C, Mavilio F, Jorcano JL, Zambruno G, Del Rio M: Longterm engraftment of single genetically modified human epidermal holoclones enables safety pre-assessment of cutaneous gene therapy. Mol Ther 2007; 15: 1670-1676. [Medline] [CrossRef]
26. Featherstone C: Epidermolysis bullosa: from fundamental molecular biology to clinical therapies. J Invest Dermatol 2007; 127: 256-259. [Medline] [CrossRef]
27. Nakano A, Chao SC, Pulkkinen L, Murrell D, Bruckner-Tuderman L, Pfendner E, Uitto J: Laminin 5 mutations in junctional epidermolysis bullosa: molecular basis of Herlitz vs. non-Herlitz phenotypes. Hum Genet 2002; 110: 41-51. [Medline] [CrossRef]
28. De Rosa L, Carulli S, Cocchiarella F, Quaglino D, Enzo E, Franchini E, Giannetti A, De Santis G, Recchia A, Pellegrini G, De Luca M: Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. Stem Cell Rep 2014; 2: 1-8. [Medline] [CrossRef]
29. Siprashvili Z, Nguyen NT, Gorell E, Khuu P, Furukawa L, Lorenz HP, Leung TH, Keene DR, Khavari P, Marinkovich M, Lane AT: Phase I clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2014; 134: 75.
30. Laimer M, Bauer JW, Klausegger A, Koller J, Pohla-Gubo G, Muss W, Sadler E, Emberger M, Lanschuetzer CM, Hametner R, Wally V, Oender K, Hinter H: Skin grafting as a therapeutic approach in pretibially restricted junctional epidermolysis bullosa. Br J Dermatol 2006; 154: 185-187. [Medline] [CrossRef]
31. Almaani N, Nagy N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Clements SE, Techanukul T, Tanaka A, Mellerio JE, McGrath JA: Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2010; 130: 1937-1940. [Medline] [CrossRef]
32. Jonkman MF, Scheffer H, Stulp R, Pas HH, Nijenhuis M, Heeres K, Owaribe K, Pulkkinen L, Uitto J: Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell 1997; 88: 543-551. [Medline] [CrossRef]
33. Gostynski A, Deviaene FC, Pasmooij AM, Pas HH, Jonkman MF: Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol 2009; 161: 444-447. [Medline] [CrossRef]